Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3.
作者信息
Humphries Romney M, Hemarajata Peera
机构信息
Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, California, USA
Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, California, USA.
出版信息
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00537-17. Print 2017 Jun.
Abstract
摘要
相似文献
1
Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3.肺炎克雷伯菌中因孔蛋白突变和KPC-3表达增加导致对头孢他啶-阿维巴坦耐药
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00537-17. Print 2017 Jun.
2
Ceftazidime-Avibactam Resistance Associated with Increased Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 .头孢他啶-阿维巴坦耐药与 258 型序列型中由 pKpQIL 质粒衍生物介导的基因拷贝数增加有关。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01816-19.
3
Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.产 KPC-23 肺炎克雷伯菌 ST258 临床分离株对头孢他啶-阿维巴坦耐药的基因组特征。
Clin Microbiol Infect. 2019 Jun;25(6):763.e5-763.e8. doi: 10.1016/j.cmi.2019.03.011. Epub 2019 Mar 28.
4
Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae.鉴定头孢他啶-阿维巴坦和亚胺培南-雷利巴坦对碳青霉烯类耐药肠杆菌科的活性谱和治疗窗。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00642-17. Print 2017 Sep.
5
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.头孢他啶-阿维巴坦对一组碳青霉烯类耐药肠杆菌科挑战株的活性：OmpK36 L3 改变和具有头孢他啶水解活性的β-内酰胺酶导致 MIC 值升高。
Int J Antimicrob Agents. 2020 Jul;56(1):106011. doi: 10.1016/j.ijantimicag.2020.106011. Epub 2020 May 15.
6
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae.头孢他啶-阿维巴坦耐药肺炎克雷伯菌临床分离株的分子分析。
Clin Microbiol Infect. 2021 Jul;27(7):1040.e1-1040.e6. doi: 10.1016/j.cmi.2021.03.001. Epub 2021 Mar 26.
7
Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases.对头孢他啶-阿维巴坦耐药、美罗培南敏感且携带变异型KPC-3碳青霉烯酶的肺炎克雷伯菌分离株进行美罗培南耐药性筛选。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.00079-17. Print 2017 May.
8
High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.高产头孢他啶水解酶活性和孔蛋白 OmpK35 缺乏导致产 KPC 肺炎克雷伯菌对头孢他啶/阿维巴坦的敏感性降低。
J Antimicrob Chemother. 2017 Jul 1;72(7):1930-1936. doi: 10.1093/jac/dkx066.
9
Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity.对头孢他啶-阿维巴坦的耐药性是由于产孔蛋白缺陷的肺炎克雷伯菌中 KPC 的转位和增加的外排活性。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.00989-17. Print 2017 Oct.
10
Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae.肺炎克雷伯菌碳青霉烯酶亚型、超广谱β-内酰胺酶及孔蛋白突变对头孢他啶-阿维巴坦体外抗碳青霉烯类耐药肺炎克雷伯菌活性的影响
Antimicrob Agents Chemother. 2015 Sep;59(9):5793-7. doi: 10.1128/AAC.00548-15. Epub 2015 Jul 13.
引用本文的文献
1
Whole-Genome Sequencing and Bioinformatics Analysis of ESBL- producing Klebsiella pneumoniae in a Ghanaian teaching hospital.加纳一家教学医院产超广谱β-内酰胺酶肺炎克雷伯菌的全基因组测序及生物信息学分析
BMC Microbiol. 2025 Jul 2;25(1):401. doi: 10.1186/s12866-025-04101-5.
2
The Triple Combination of Meropenem, Avibactam, and a Metallo-β-Lactamase Inhibitor Optimizes Antibacterial Coverage Against Different β-Lactamase Producers.美罗培南、阿维巴坦和一种金属β-内酰胺酶抑制剂的三联组合优化了针对不同β-内酰胺酶产生菌的抗菌覆盖范围。
Engineering (Beijing). 2024 Jul;38:124-132. doi: 10.1016/j.eng.2024.02.010.
3
Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria.多药耐药革兰氏阴性菌中外排泵介导的对新型β-内酰胺类抗生素的耐药性
Commun Med (Lond). 2024 Aug 29;4(1):170. doi: 10.1038/s43856-024-00591-y.
4
The burden of antibiotic resistance of the main microorganisms causing infections in humans - review of the literature.主要引起人类感染的微生物的抗生素耐药负担——文献综述。
J Med Life. 2024 Mar;17(3):246-260. doi: 10.25122/jml-2023-0404.
5
Loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing K1-ST23 hypervirulent .非产碳青霉烯酶 K1-ST23 超毒力株中头孢他啶-阿维巴坦敏感性的丧失与获得。
Virulence. 2024 Dec;15(1):2348251. doi: 10.1080/21505594.2024.2348251. Epub 2024 May 2.
6
Exploring the resistome, virulome, and mobilome of multidrug-resistant Klebsiella pneumoniae isolates: deciphering the molecular basis of carbapenem resistance.探索多药耐药肺炎克雷伯菌分离株的耐药组、毒力组和可移动组：解析碳青霉烯类耐药的分子基础。
BMC Genomics. 2024 Apr 25;25(1):408. doi: 10.1186/s12864-024-10139-y.
7
Clinical distribution of carbapenem genotypes and resistance to ceftazidime-avibactam in Enterobacteriaceae bacteria.肠杆菌科细菌中产碳青霉烯酶基因型的临床分布及对头孢他啶-阿维巴坦的耐药性。
Front Cell Infect Microbiol. 2024 Mar 20;14:1345935. doi: 10.3389/fcimb.2024.1345935. eCollection 2024.
8
Mobilization of the gene among heterogenous plasmids in extensively drug-resistant hypervirulent .广泛耐药性高毒力菌株中基因在异质质粒间的转移
Front Microbiol. 2023 Nov 15;14:1261261. doi: 10.3389/fmicb.2023.1261261. eCollection 2023.
9
Emergence of KPC-113 and KPC-114 variants in ceftazidime-avibactam-resistant belonging to high-risk clones ST11 and ST16 in South America.在南美洲，属于高风险克隆株ST11和ST16的对头孢他啶-阿维巴坦耐药菌株中出现了KPC-113和KPC-114变体。
Microbiol Spectr. 2023 Sep 6;11(5):e0037423. doi: 10.1128/spectrum.00374-23.
10
Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant -Producing Carrying .携带产头孢他啶-阿维巴坦耐药菌的新生儿血流感染
Antibiotics (Basel). 2023 Aug 5;12(8):1290. doi: 10.3390/antibiotics12081290.
本文引用的文献
1
Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.产 blaOXA-232 基因碳青霉烯耐药肺炎克雷伯菌的进化和传播：与内镜逆行胰胆管造影术相关的医院感染事件
Clin Infect Dis. 2017 Apr 1;64(7):894-901. doi: 10.1093/cid/ciw876.
2
Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying Collected in U.S. Hospitals from 2012 to 2015.2012年至2015年在美国医院收集的携带[相关因素未给出]的肠杆菌科分离株中头孢他啶-阿维巴坦耐药的低发生率
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02369-16. Print 2017 Mar.
3
Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.外膜和孔蛋白在产β-内酰胺酶肠杆菌科细菌对头孢他啶-阿维巴坦敏感性中的作用
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1349-59. doi: 10.1128/AAC.01585-15.
4
Genomic Analysis of the Emergence and Rapid Global Dissemination of the Clonal Group 258 Klebsiella pneumoniae Pandemic.258型肺炎克雷伯菌大流行株的出现及在全球快速传播的基因组分析
PLoS One. 2015 Jul 21;10(7):e0133727. doi: 10.1371/journal.pone.0133727. eCollection 2015.
5
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate.产KPC-3型肺炎克雷伯菌分离株中头孢他啶-阿维巴坦耐药性的首次报告
Antimicrob Agents Chemother. 2015 Oct;59(10):6605-7. doi: 10.1128/AAC.01165-15. Epub 2015 Jul 20.
6
Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae.肺炎克雷伯菌碳青霉烯酶亚型、超广谱β-内酰胺酶及孔蛋白突变对头孢他啶-阿维巴坦体外抗碳青霉烯类耐药肺炎克雷伯菌活性的影响
Antimicrob Agents Chemother. 2015 Sep;59(9):5793-7. doi: 10.1128/AAC.00548-15. Epub 2015 Jul 13.
7
Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.针对从美国医院分离出的肠杆菌科细菌（2011年至2013年）进行的头孢他啶-阿维巴坦活性测试以及产β-内酰胺酶菌株的特征分析。
Antimicrob Agents Chemother. 2015;59(6):3509-17. doi: 10.1128/AAC.00163-15. Epub 2015 Apr 6.
8
Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013.2011 年至 2013 年期间，加利福尼亚州洛杉矶某医疗体系中产碳青霉烯类耐药肠杆菌科细菌的表型和分子特征。
J Clin Microbiol. 2014 Nov;52(11):4003-9. doi: 10.1128/JCM.01397-14. Epub 2014 Sep 10.
9
Role of ISKpn7 and deletions in blaKPC gene expression.ISKpn7 的作用和 blaKPC 基因表达中的缺失。
Antimicrob Agents Chemother. 2012 Sep;56(9):4753-9. doi: 10.1128/AAC.00334-12. Epub 2012 Jun 25.
10
Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.美罗培南治疗期间产生的肺炎克雷伯菌对碳青霉烯类药物敏感性迅速降低。
Clin Microbiol Infect. 2012 Feb;18(2):140-6. doi: 10.1111/j.1469-0691.2011.03515.x. Epub 2011 Jul 11.
Zotero 插件